Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Jan 07, 2021 $156.73 $157.47 $155.75 $155.75 4 424 576
Jan 06, 2021 $157.35 $158.95 $157.23 $157.76 2 956 371
Jan 05, 2021 $156.24 $157.80 $155.83 $157.36 2 667 372
Jan 04, 2021 $157.61 $158.20 $155.43 $156.81 3 642 344
Dec 31, 2020 $155.81 $156.35 $154.23 $156.24 1 228 256
Dec 30, 2020 $156.51 $156.96 $155.93 $156.23 1 886 556
Dec 29, 2020 $156.99 $157.15 $155.27 $155.35 2 836 509
Dec 28, 2020 $155.90 $156.24 $153.90 $154.36 2 633 853
Dec 24, 2020 $153.54 $153.61 $151.99 $152.63 1 083 879
Dec 23, 2020 $154.15 $154.23 $153.16 $153.24 4 203 392
Dec 22, 2020 $154.00 $154.17 $152.74 $153.81 2 926 593
Dec 21, 2020 $154.96 $155.64 $153.81 $154.83 3 773 222
Dec 18, 2020 $157.96 $158.21 $155.83 $156.75 5 941 202
Dec 17, 2020 $158.00 $159.18 $157.16 $157.93 5 486 358
Dec 16, 2020 $159.68 $160.03 $157.80 $158.03 7 388 050
Dec 15, 2020 $157.44 $158.00 $156.68 $157.91 7 304 925
Dec 14, 2020 $157.35 $160.03 $155.98 $156.31 22 326 137
Dec 11, 2020 $118.74 $121.39 $118.11 $120.98 1 374 980
Dec 10, 2020 $117.51 $120.05 $117.22 $118.87 979 022
Dec 09, 2020 $120.10 $120.50 $116.61 $117.74 1 129 526
Dec 08, 2020 $119.07 $120.20 $118.70 $119.22 1 037 692
Dec 07, 2020 $119.75 $120.89 $118.05 $118.83 1 372 905
Dec 04, 2020 $121.05 $121.46 $119.40 $120.51 999 031
Dec 03, 2020 $122.26 $122.73 $120.11 $121.06 1 045 300
Dec 02, 2020 $121.76 $123.50 $121.18 $122.75 804 878
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT